Articles with "outcomes metastatic" as a keyword



Photo by atikahakhtar from unsplash

Clinical Outcomes of Metastatic Melanoma Treated With Checkpoint Inhibitors and Multisite Radiotherapy

Sign Up to like & get
recommendations!
Published in 2017 at "JAMA Dermatology"

DOI: 10.1001/jamadermatol.2017.2222

Abstract: Discussion | Although narrow-band UV-B phototherapy is the most widely used treatment modality for patients with vitiligo, it is associated with unnecessary UV exposure to normal skin.3 Because a majority of patients have limited involvement… read more here.

Keywords: tsl; clinical outcomes; 311 tsl; treatment ... See more keywords
Photo by nci from unsplash

Analysis of outcomes in metastatic pancreatic cancer: Real-world experience in academic cancer centers.

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2017.35.4_suppl.458

Abstract: 458Background: FOLFIRINOX is an active regimen for metastatic pancreatic cancer demonstrating a median overall survival of 11.1 months at the expense of significant treatment-related toxicity. Dose modifications are routinely used in clinical practice however there… read more here.

Keywords: metastatic pancreatic; analysis outcomes; pancreatic cancer; cancer real ... See more keywords
Photo by nci from unsplash

Impact of treatment sequence on the outcomes of metastatic castration resistant prostate cancer patients (mCRPC) with germline BRCA2 mutations: A subanalysis of the PROREPAIR-B study.

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2018.36.15_suppl.5071

Abstract: 5071Background: Germline mutations in BRCA2 have been identified in 3-5% of mCRPC patients. PROREPAIR-B (Castro et al ESMO 2017) is the first prospective study to report a worse survival from mCRPC... read more here.

Keywords: treatment sequence; sequence outcomes; metastatic castration; castration resistant ... See more keywords
Photo by gabrielepmattia from unsplash

Outcomes for metastatic colorectal cancer (mCRC) based on microsatellite instability.

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2018.36.4_suppl.759

Abstract: 759Background: Microsatellite instability (MSI) has been associated with improved survival outcomes in early stage CRC. In stage IV disease, MSI represents only 3-5% of cases and currently the prognostic implications are less clear. There is… read more here.

Keywords: metastatic colorectal; mcrc; msi; microsatellite instability ... See more keywords
Photo by nci from unsplash

Mutational profiles and clinical outcomes in metastatic colorectal carcinoma patients with different metastases sites.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.15_suppl.e16020

Abstract: e16020Background: To compare the difference of genomic and survival of first metastases site between first metastases site of metastatic colorectal cancer (mCRC) in liver and other sites (bone, bra... read more here.

Keywords: metastatic colorectal; mutational profiles; clinical outcomes; colorectal carcinoma ... See more keywords
Photo by nci from unsplash

Evolution of clinical outcomes of metastatic pancreatic adenocarcinoma: A 10-year single-institution retrospective study.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.15_suppl.e16760

Abstract: e16760Background: Pancreatic adenocarcinoma represents the fourth leading cause of cancer-related death in the United States. A majority of patients have locally advanced or metastatic disease at t... read more here.

Keywords: metastatic pancreatic; clinical outcomes; pancreatic adenocarcinoma; evolution clinical ... See more keywords
Photo from wikipedia

Improvement of Treatment Outcomes for Metastatic Pancreatic Cancer: A Real-world Data Analysis

Sign Up to like & get
recommendations!
Published in 2018 at "In Vivo"

DOI: 10.21873/invivo.11471

Abstract: Background/Aim: FOLFIRINOX (5-fluorouracil, leucovorin, irinotecan, oxaliplatin) and gemcitabine plus nab-paclitaxel therapy have recently been introduced for the treatment of metastatic pancreatic cancer. Herein, overall treatment outcomes of metastatic pancreatic cancer after introduction of FOLFIRINOX and… read more here.

Keywords: treatment outcomes; metastatic pancreatic; outcomes metastatic; pancreatic cancer ... See more keywords